Search Results
Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapies
Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies
Sandip Patel, MD, on identifying patient types likely to experience immune-related adverse events
Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life
Sandip Patel, MD, considers immunotherapy combinations and the likelihood of severe adverse events
Dr. Patel on Primary and Adaptive Resistance to Immunotherapy in NSCLC
Sandip Patel, MD | Perspective on Cancer Care in the Time of COVID-19
Sandip Patel, MD, on treating non-squamous NSCLC patients expressing high levels of PD-L1
Sandip Patel, MD | Addressing Patients on Cancer Care in the Time of COVID-19
Copy of Dr. Patel on Novel Agents for Patients With NSCLC
Lung Cancer Video Library - Combinations of Immunotherapy Agents in Advanced NSCLC: Current Status
NSCLC: Immunotherapy Toxicity Management
